Cs. Thomson et al., Prognostic factors in women with breast cancer: distribution by socioeconomic status and effect on differences in survival, J EPIDEM C, 55(5), 2001, pp. 308-315
Citations number
31
Categorie Soggetti
Envirnomentale Medicine & Public Health","Medical Research General Topics
Study objective-To quantify and investigate differences in survival from br
east cancer between women resident in affluent and deprived areas and defin
e the contribution of underlying factors to this variation.
Design-Analysis of two datasets relating to breast cancer patients in Scotl
and: (1) population-based cancer registry data; (2) a subset of cancer regi
stration records supplemented by abstraction of prognostic variables (stage
, node status, tumour size, oestrogen receptor (ER) status, type of surgery
, use of radiotherapy and use of adjuvant systemic therapy) from medical re
cords.
Setting-Scotland.
Patients-(1) Cancer registration data on 21 751 women aged under 85 years d
iagnosed with primary breast cancer between 1978 and 1987; (2) national cli
nical audit data on 2035 women aged under 85 years diagnosed with primary b
reast cancer during 1987 for whom adequate medical records were available.
Main results-Survival differences of 10% between affluent and deprived wome
n were observed in both datasets, across all age groups. In the audit datas
et, the distribution of ER status varied by deprivation group (65% ER posit
ive in affluent group v 48% ER positive in deprived group; under 65 age gro
up). Women aged under 65 with non-metastatic disease were more likely to ha
ve breast conservation than a mastectomy if they were affluent (45%) than d
eprived (32%); the affluent were more likely to receive endocrine therapy (
65%) than the deprived (50%). However, these factors accounted for about 20
% of the observed difference in survival between women resident in affluent
and deprived areas.
Conclusions-Deprived women with breast cancer have poorer outcomes than aff
luent women. This can only partly be explained by deprived women having mor
e ER negative tumours than affluent women. Further research is required to
identify other reasons for poorer outcomes in deprived women, with a view t
o reducing these survival differences.